Xtoro FDA Approval History
FDA Approved: Yes (Discontinued) (First approved December 17, 2014)
Brand name: Xtoro
Generic name: finafloxacin
Dosage form: Otic Suspension
Company: Alcon Laboratories, Inc.
Treatment for: Otitis Externa
Marketing Status: Discontinued
Xtoro (finafloxacin otic suspension) is a fluoroquinolone antimicrobial for the treatment of acute otitis externa, commonly known as swimmer’s ear.
Development Timeline for Xtoro
|Dec 17, 2014||Approval FDA Approves Xtoro (finafloxacin) Otic Suspension to Treat Swimmer’s Ear|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.